$NVDL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVADEL PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NOVADEL PHARMA INC. Get notifications about new insider transactions in NOVADEL PHARMA INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2012 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | J | 0.04 | 14,696,117 | 520,243 | 17,120,360 | |
Jun 27 2011 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 0.06 | 50,000 | 3,000 | 294,467 | |
Jun 27 2011 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 0.06 | 50,000 | 3,000 | 257,500 | |
Nov 19 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | X | 0.19 | 1,394,871 | 263,352 | 0 | |
Nov 19 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Buy | X | 1.89 | 297,571 | 561,814 | 34,650,709 | 34.4 M to 34.7 M (+0.87 %) |
Jun 17 2010 | NVDL | NOVADEL PHARMA INC | Johnson Craig A | Sr. VP, CFO and Sec ... | Option Exercise | A | 0.19 | 750,000 | 142,500 | 750,000 | |
Jun 14 2010 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 0.20 | 50,000 | 10,000 | 257,500 | |
Jun 14 2010 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 0.20 | 50,000 | 10,000 | 294,467 | |
Apr 01 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 0.25 | 1,616,162 | 404,041 | 1,616,162 | |
Apr 01 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 0.25 | 2,424,243 | 606,061 | 2,424,243 | |
Apr 01 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Buy | P | 0.17 | 4,848,485 | 800,000 | 34,353,138 | 29.5 M to 34.4 M (+16.43 %) |
Jun 14 2010 | NVDL | NOVADEL PHARMA INC | Baric Mark J | Director | Option Exercise | A | 0.20 | 50,000 | 10,000 | 250,000 | |
Jan 07 2010 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | President and CEO | Option Exercise | A | 0.17 | 2,000,000 | 340,000 | 3,568,372 | |
Jan 05 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | C | 0.24 | 10,744,681 | 2,525,000 | 0 | |
Jan 05 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | C | 0.30 | 2,069,074 | 610,377 | 0 | |
Jan 05 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | C | 0.19 | 220,726 | 41,673 | 1,394,871 | |
Jan 05 2010 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Buy | C | 0.16 | 23,237,083 | 3,657,517 | 29,504,653 | 6.3 M to 29.5 M (+370.75 %) |
Dec 14 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Buy | P | 0.13 | 8,000 | 1,075 | 1,560,000 | 1.6 M to 1.6 M (+0.52 %) |
Dec 14 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Buy | P | 0.15 | 26,200 | 3,930 | 1,552,000 | 1.5 M to 1.6 M (+1.72 %) |
Dec 14 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Buy | P | 0.18 | 465,800 | 81,701 | 1,525,800 | 1.1 M to 1.5 M (+43.94 %) |
Dec 14 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Buy | P | 0.15 | 236,134 | 35,326 | 1,060,000 | 823.9 K to 1.1 M (+28.66 %) |
Dec 14 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Buy | P | 0.14 | 263,866 | 37,179 | 823,866 | 560 K to 823.9 K (+47.12 %) |
Dec 01 2009 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | Chief Operating Off ... | Option Exercise | A | 0.23 | 700,000 | 161,000 | 2,000,000 | |
Oct 19 2009 | NVDL | NOVADEL PHARMA INC | Baric Mark J | Director | Option Exercise | A | 0.23 | 50,000 | 11,500 | 200,000 | |
Oct 19 2009 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 0.23 | 50,000 | 11,500 | 344,467 | |
Oct 19 2009 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 0.23 | 50,000 | 11,500 | 301,000 | |
Oct 19 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Option Exercise | A | 0.23 | 50,000 | 11,500 | 1,568,372 | |
May 05 2009 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | J | 0.30 | 2,930,926 | 864,623 | 2,069,074 | |
Jan 26 2009 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Option Exercise | A | 0.34 | 1,250,000 | 425,000 | 1,518,372 | |
Jan 26 2009 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | Chief Operating Off ... | Option Exercise | A | 0.34 | 400,000 | 136,000 | 1,300,000 | |
Jan 26 2009 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Secretary | Option Exercise | A | 0.34 | 125,000 | 42,500 | 900,000 | |
Jan 26 2009 | NVDL | NOVADEL PHARMA INC | ZODDA DENI M PHD | SVP and Chief Busin ... | Option Exercise | A | 0.34 | 125,000 | 42,500 | 792,000 | |
Dec 30 2008 | NVDL | NOVADEL PHARMA INC | Baric Mark J | Director | Option Exercise | A | 0.24 | 50,000 | 12,000 | 150,000 | |
Dec 30 2008 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | A | 0.24 | 50,000 | 12,000 | 298,173 | |
Dec 30 2008 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Chief Executive Off ... | Option Exercise | A | 0.24 | 50,000 | 12,000 | 268,372 | |
Dec 30 2008 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 0.24 | 50,000 | 12,000 | 294,467 | |
Dec 30 2008 | NVDL | NOVADEL PHARMA INC | LOBELL J JAY | Director | Option Exercise | A | 0.24 | 50,000 | 12,000 | 295,685 | |
Dec 29 2008 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 0.24 | 50,000 | 12,000 | 251,000 | |
Dec 29 2008 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 0.21 | 7,500 | 1,575 | 258,500 | |
Dec 29 2008 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 0.21 | 50,000 | 10,500 | 251,000 | |
Dec 23 2008 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 0.29 | 6,446,809 | 1,895,362 | 6,446,809 | |
Dec 23 2008 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 0.24 | 10,744,681 | 2,525,000 | 10,744,681 | |
Jun 25 2008 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 0.37 | 3,000,000 | 1,107,000 | 3,000,000 | |
Jun 25 2008 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 0.30 | 5,000,000 | 1,475,000 | 5,000,000 | |
Feb 07 2008 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Grant | A | 0.00 | 300,000 | 0 | 560,000 | 260 K to 560 K (+115.38 %) |
Feb 07 2008 | NVDL | NOVADEL PHARMA INC | ZODDA DENI M PHD | SVP and Chief Busin ... | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
Feb 07 2008 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | SVP & Chief Operati ... | Grant | A | 0.00 | 150,000 | 0 | 190,000 | 40 K to 190 K (+375.00 %) |
Feb 07 2008 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Corporate S ... | Grant | A | 0.00 | 150,000 | 0 | 189,000 | 39 K to 189 K (+384.62 %) |
Sep 04 2007 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Buy | P | 0.80 | 4,000 | 3,200 | 9,000 | 5 K to 9 K (+80.00 %) |
Sep 04 2007 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Buy | P | 0.68 | 4,900 | 3,332 | 5,000 | 100 to 5 K (+4,900.00 %) |
Sep 04 2007 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Buy | P | 0.68 | 100 | 68 | 100 | 0 to 100 |
Aug 31 2007 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Buy | P | 0.79 | 5,300 | 4,187 | 25,300 | 20 K to 25.3 K (+26.50 %) |
Aug 29 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.73 | 2,310 | 1,686 | 260,000 | 257.7 K to 260 K (+0.90 %) |
Aug 29 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.73 | 3,600 | 2,628 | 257,690 | 254.1 K to 257.7 K (+1.42 %) |
Aug 29 2007 | NVDL | NOVADEL PHARMA INC | Baric Mark J | Director | Buy | P | 0.80 | 4,900 | 3,920 | 5,000 | 100 to 5 K (+4,900.00 %) |
Aug 29 2007 | NVDL | NOVADEL PHARMA INC | Baric Mark J | Director | Buy | P | 0.69 | 100 | 69 | 100 | 0 to 100 |
Aug 28 2007 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Buy | P | 0.68 | 15,000 | 10,200 | 15,000 | 0 to 15 K |
Aug 28 2007 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | SVP & Chief Operati ... | Buy | P | 0.65 | 40,000 | 26,044 | 40,000 | 0 to 40 K |
Aug 27 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.65 | 6,300 | 4,095 | 254,090 | 247.8 K to 254.1 K (+2.54 %) |
Aug 24 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.65 | 39,300 | 25,545 | 247,790 | 208.5 K to 247.8 K (+18.85 %) |
Aug 23 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.64 | 4,400 | 2,830 | 208,490 | 204.1 K to 208.5 K (+2.16 %) |
Aug 22 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.61 | 50,000 | 30,350 | 204,090 | 154.1 K to 204.1 K (+32.45 %) |
Aug 21 2007 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Corporate S ... | Buy | P | 0.66 | 22,400 | 14,784 | 39,000 | 16.6 K to 39 K (+134.94 %) |
Aug 21 2007 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Corporate S ... | Buy | P | 0.64 | 3,500 | 2,240 | 16,600 | 13.1 K to 16.6 K (+26.72 %) |
Aug 21 2007 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Corporate S ... | Buy | P | 0.63 | 4,100 | 2,583 | 13,100 | 9 K to 13.1 K (+45.56 %) |
Aug 21 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 0.60 | 25,000 | 14,925 | 154,090 | 129.1 K to 154.1 K (+19.37 %) |
Feb 05 2007 | NVDL | NOVADEL PHARMA INC | Baric Mark J | Director | Option Exercise | A | 1.54 | 100,000 | 154,000 | 100,000 | |
Jan 30 2007 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Corporate S ... | Option Exercise | A | 1.81 | 169,752 | 307,251 | 169,752 | |
Jan 30 2007 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | CFO and Corporate S ... | Option Exercise | A | 1.81 | 55,248 | 99,999 | 55,248 | |
Jan 26 2007 | NVDL | NOVADEL PHARMA INC | ProQuest Investments III, L.P. | 10% Owner | Option Exercise | P | 1.70 | 1,751,854 | 2,978,152 | 1,751,854 | |
Jan 26 2007 | NVDL | NOVADEL PHARMA INC | ProQuest Investments III, L.P. | 10% Owner | Buy | P | 1.45 | 763,449 | 1,107,001 | 4,974,426 | 4.2 M to 5 M (+18.13 %) |
Jan 30 2007 | NVDL | NOVADEL PHARMA INC | Egberts Jan H | President and CEO | Option Exercise | A | 1.81 | 1,194,752 | 2,162,501 | 1,194,752 | |
Jan 30 2007 | NVDL | NOVADEL PHARMA INC | Egberts Jan H | President and CEO | Option Exercise | A | 1.81 | 55,248 | 99,999 | 55,248 | |
Jan 23 2007 | NVDL | NOVADEL PHARMA INC | ROSENWALD LINDSAY A MD | 10% Owner | Gift | G | 0.00 | 18,000 | 0 | 2,137,660 | 2.2 M to 2.1 M (-0.84 %) |
Jan 26 2007 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 1.70 | 384,776 | 654,119 | 384,776 | |
Jan 26 2007 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Buy | P | 1.45 | 961,914 | 1,394,775 | 6,267,570 | 5.3 M to 6.3 M (+18.13 %) |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Option Exercise | A | 1.52 | 29,645 | 45,060 | 29,645 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Option Exercise | A | 1.52 | 50,000 | 76,000 | 50,000 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 1.52 | 50,000 | 76,000 | 50,000 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | LOBELL J JAY | Director | Option Exercise | A | 1.52 | 50,000 | 76,000 | 50,000 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | A | 1.52 | 48,173 | 73,223 | 48,173 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | A | 1.52 | 50,000 | 76,000 | 50,000 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 1.52 | 44,467 | 67,590 | 44,467 | |
Jan 18 2007 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 1.52 | 50,000 | 76,000 | 50,000 | |
Dec 06 2006 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | SVP & Chief Operati ... | Option Exercise | A | 1.71 | 100,000 | 171,000 | 100,000 | |
Dec 06 2006 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | SVP & Chief Operati ... | Option Exercise | A | 1.71 | 841,521 | 1,439,001 | 841,521 | |
Dec 06 2006 | NVDL | NOVADEL PHARMA INC | Bergstrom David H | SVP & Chief Operati ... | Option Exercise | A | 1.71 | 58,479 | 99,999 | 58,479 | |
Jul 05 2006 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Buy | P | 1.32 | 19,500 | 25,740 | 19,500 | 0 to 19.5 K |
Jun 27 2006 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | Chief Financial Off ... | Buy | P | 1.38 | 1,500 | 2,070 | 9,000 | 7.5 K to 9 K (+20.00 %) |
May 16 2006 | NVDL | NOVADEL PHARMA INC | ROSENWALD LINDSAY A MD | 10% Owner | Gift | G | 0.00 | 2,900,000 | 0 | 2,155,660 | 5.1 M to 2.2 M (-57.36 %) |
Apr 21 2006 | NVDL | NOVADEL PHARMA INC | ROSENWALD LINDSAY A MD | 10% Owner | Option Exercise | J | 1.60 | 103,390 | 165,424 | 7,283,266 | |
Apr 27 2006 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | Chief Financial Off ... | Option Exercise | A | 1.65 | 389,394 | 642,500 | 389,394 | |
Apr 27 2006 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | Chief Financial Off ... | Option Exercise | A | 1.65 | 60,606 | 100,000 | 60,606 | |
Apr 21 2006 | NVDL | NOVADEL PHARMA INC | LOBELL J JAY | Director | Option Exercise | J | 0.59 | 11,946 | 7,048 | 61,946 | |
Apr 21 2006 | NVDL | NOVADEL PHARMA INC | LOBELL J JAY | Director | Option Exercise | P | 1.60 | 9,494 | 15,190 | 9,494 | |
Apr 21 2006 | NVDL | NOVADEL PHARMA INC | LOBELL J JAY | Director | Buy | P | 1.58 | 31,646 | 50,001 | 177,464 | 145.8 K to 177.5 K (+21.70 %) |
Apr 21 2006 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Option Exercise | J | 1.60 | 38,727 | 61,963 | 38,727 | |
Apr 21 2006 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Buy | P | 1.58 | 129,090 | 203,962 | 129,090 | 0 to 129.1 K |
Apr 14 2006 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Option Exercise | P | 1.62 | 206,896 | 335,172 | 206,896 | |
Apr 14 2006 | NVDL | NOVADEL PHARMA INC | Moorin Jay | 10% Owner | Buy | P | 1.45 | 689,656 | 1,000,001 | 5,305,649 | 4.6 M to 5.3 M (+14.94 %) |
Jan 19 2006 | NVDL | NOVADEL PHARMA INC | RATOFF STEVEN B | Director | Option Exercise | A | 1.36 | 100,000 | 136,000 | 100,000 | |
Jan 18 2006 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 1.36 | 50,000 | 68,000 | 50,000 | |
Jan 23 2006 | NVDL | NOVADEL PHARMA INC | ROSENWALD LINDSAY A MD | 10% Owner | Option Exercise | J | 0.46 | 2,328,637 | 1,078,625 | 6,278,637 | |
Jan 18 2006 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | A | 1.36 | 50,000 | 68,000 | 50,000 | |
Jan 18 2006 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 1.36 | 50,000 | 68,000 | 50,000 | |
Jan 03 2006 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | Chief Financial Off ... | Buy | P | 1.18 | 5,000 | 5,900 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
Dec 16 2005 | NVDL | NOVADEL PHARMA INC | LOBELL J JAY | Director | Option Exercise | A | 1.25 | 100,000 | 125,000 | 100,000 | |
Sep 28 2005 | NVDL | NOVADEL PHARMA INC | Egberts Jan H | Chief Operating Off ... | Option Exercise | A | 1.70 | 1,622,700 | 2,758,590 | 1,622,700 | |
Sep 07 2005 | NVDL | NOVADEL PHARMA INC | SAVAGE ROBERT G | Chairman of the Boa ... | Option Exercise | A | 1.52 | 400,000 | 608,000 | 400,000 | |
Aug 19 2005 | NVDL | NOVADEL PHARMA INC | ROSENWALD LINDSAY A MD | 10% Owner | Option Exercise | J | 1.30 | 162,664 | 211,463 | 162,664 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | D | 1.41 | 50,000 | 70,500 | 0 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | RACHESKY MARK H MD | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | RACHESKY MARK H MD | Director | Option Exercise | D | 1.41 | 50,000 | 70,500 | 0 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | SAVAGE ROBERT G | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | SAVAGE ROBERT G | Director | Option Exercise | D | 1.41 | 50,000 | 70,500 | 0 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | D | 1.41 | 50,000 | 70,500 | 0 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | KESSEL LARRY | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | KESSEL LARRY | Director | Option Exercise | D | 1.41 | 50,000 | 70,500 | 0 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | FRYDMAN JEAN W | VP & General Counse ... | Option Exercise | A | 1.98 | 100,000 | 198,000 | 100,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | FRYDMAN JEAN W | VP & General Counse ... | Option Exercise | D | 1.98 | 100,000 | 198,000 | 0 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | A | 1.38 | 100,000 | 138,000 | 100,000 | |
Aug 01 2005 | NVDL | NOVADEL PHARMA INC | Bonney Thomas E | Director | Option Exercise | D | 1.38 | 100,000 | 138,000 | 0 | |
Jul 01 2005 | NVDL | NOVADEL PHARMA INC | SPICER MICHAEL E B | Chief Financial Off ... | Buy | P | 1.20 | 2,500 | 3,000 | 2,500 | 0 to 2.5 K |
Jun 30 2005 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.23 | 7,500 | 9,225 | 76,000 | 68.5 K to 76 K (+10.95 %) |
Jun 30 2005 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.22 | 16,500 | 20,130 | 68,500 | 52 K to 68.5 K (+31.73 %) |
Jun 30 2005 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.21 | 1,000 | 1,210 | 52,000 | 51 K to 52 K (+1.96 %) |
Jun 30 2005 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.22 | 1,000 | 1,220 | 51,000 | 50 K to 51 K (+2.00 %) |
Mar 02 2005 | NVDL | NOVADEL PHARMA INC | RACHESKY MARK H MD | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Mar 02 2005 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Mar 02 2005 | NVDL | NOVADEL PHARMA INC | Nemeroff Charles | Director | Option Exercise | A | 1.51 | 1,000 | 1,510 | 1,000 | |
Mar 02 2005 | NVDL | NOVADEL PHARMA INC | HAMILTON WILLIAM F PHD | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Mar 02 2005 | NVDL | NOVADEL PHARMA INC | KESSEL LARRY | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Mar 02 2005 | NVDL | NOVADEL PHARMA INC | SAVAGE ROBERT G | Director | Option Exercise | A | 1.41 | 50,000 | 70,500 | 50,000 | |
Jan 26 2005 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Option Exercise | A | 1.47 | 32,000 | 47,040 | 32,000 | |
Jan 26 2005 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Option Exercise | A | 1.47 | 68,000 | 99,960 | 68,000 | |
Jan 26 2005 | NVDL | NOVADEL PHARMA INC | Cohen Barry | VP, Product & Bus D ... | Option Exercise | A | 1.47 | 50,000 | 73,500 | 50,000 | |
Jan 25 2005 | NVDL | NOVADEL PHARMA INC | FRYDMAN JEAN W | VP, and General Cou ... | Option Exercise | A | 1.47 | 50,000 | 73,500 | 50,000 | |
Dec 23 2004 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.55 | 21,700 | 33,635 | 50,000 | 28.3 K to 50 K (+76.68 %) |
Dec 23 2004 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.50 | 18,300 | 27,450 | 28,300 | 10 K to 28.3 K (+183.00 %) |
Dec 23 2004 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.49 | 8,600 | 12,814 | 10,000 | 1.4 K to 10 K (+614.29 %) |
Dec 23 2004 | NVDL | NOVADEL PHARMA INC | Shangold Gary A | President & CEO | Buy | P | 1.48 | 1,400 | 2,072 | 1,400 | 0 to 1.4 K |
Dec 22 2004 | NVDL | NOVADEL PHARMA INC | Cohen Barry | VP, Product & Busin ... | Buy | P | 1.47 | 5,000 | 7,350 | 5,000 | 0 to 5 K |
Oct 29 2004 | NVDL | NOVADEL PHARMA INC | ROSENWALD LINDSAY A MD | 10% Owner | Gift | G | 0.00 | 10,000 | 0 | 5,065,660 | 5.1 M to 5.1 M (-0.20 %) |
Jul 06 2004 | NVDL | NOVADEL PHARMA INC | DUGGER HARRY A III PH D | Sell | S | 1.90 | 7,700 | 14,630 | 1,145,503 | 1.2 M to 1.1 M (-0.67 %) | |
Jul 06 2004 | NVDL | NOVADEL PHARMA INC | DUGGER HARRY A III PH D | Sell | S | 1.92 | 7,700 | 14,784 | 1,153,203 | 1.2 M to 1.2 M (-0.66 %) | |
Jun 30 2004 | NVDL | NOVADEL PHARMA INC | DUGGER HARRY A III PH D | Sell | S | 2.00 | 7,700 | 15,400 | 1,160,903 | 1.2 M to 1.2 M (-0.66 %) | |
Jun 30 2004 | NVDL | NOVADEL PHARMA INC | DUGGER HARRY A III PH D | Sell | S | 1.90 | 7,700 | 14,630 | 1,168,603 | 1.2 M to 1.2 M (-0.65 %) | |
Jun 30 2004 | NVDL | NOVADEL PHARMA INC | DUGGER HARRY A III PH D | Sell | S | 1.90 | 7,700 | 14,630 | 1,176,303 | 1.2 M to 1.2 M (-0.65 %) |